semaglutide sales 2024 Company of the Year 2024: Novo Nordisk – Continuing triumph Semaglutides Market Share Analysis And

Small, protein-dense snacks aren't a workaround

And while the disease itself creates chronic inflammation that disrupts metabolism, the treatments often make weight management even harder

As the evidence base solidifies, the future of OA care lies in personalization, tailoring nutritional plans based on genetics, gut microbiota, and individual metabolic profiles

Cardiovascular and metabolic diseases including obesity remain important areas of unmet medical need, and we plan to continue applying our global capabilities to advance a pipeline of investigational treatments that have the potential to fill critical gaps in patient care, including continued development of our oral GIPR antagonist candidate and other earlier obesity programs, said Chris Boshoff, MD, PhD, Chief Scientific Officer and President, Research and Development at Pfizer

It holds no MHRA or EMA marketing authorisation and is available only through approved clinical trials or regulated NHS specials pathways